Apparent cortisone reductase deficiency: A functional defect in 11β-hydroxysteroid dehydrogenase type 1

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3570-3574

  Jamieson, A ^a   Wallace, A M ^b   Andrew, R ^e   Nunez, B S ^d   Walker, B R ^c   Fraser, Robert ^a   White, P C ^a,d   Connell, J M C ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; CORTISONE; CORTISONE ACETATE; CYPROTERONE ACETATE; DEXAMETHASONE; DIANE; ETHINYLESTRADIOL; HYDROCORTISONE; TETRAHYDROCORTISONE;

ACNE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG METABOLISM; ENZYME DEFECT; ENZYME DEFICIENCY; FEMALE; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; OLIGOMENORRHEA; PRIORITY JOURNAL;

EID: 0033304914     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6031     Document Type: Article

References (36)

1. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor
2. 11β-Hydroxysteroid dehydrogenase
3. 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation
4. +-dependent isoform of 11β-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney
5. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme
6. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol
7. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle
8. Hypertension in mice caused by inactivation of 11β-hydroxysteroid dehydrogenase type 2
9. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase comes of age
10. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome
11. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: Effect of physicochemical and hormonal manipulations
12. Carbenoxolone increases hepatic insulin sensitivity in man: A novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation
13. 11β-Hyroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglcaemia on obesity and stress
14. Does central obesity reflect 'Cushing's disease of the omentum'?
15. 11β-Hydroxysteroid dehydrogenase 1 in adipocytes: Expression is differentiation-dependent and hormonally regulated
16. 11β-Hydroxysteroid dehydrogenase in cultured hippocampal cells reactivates inert 11-dehydrocorticosterone, potentiating neurotoxicity
17. Adrenal 11β-hydroxysteroid dehydrogenase
18. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase
19. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase
20. Several homozygous mutations in the gene for 11β-hydroxysteroid dehydrogenase type 2 in patients with apparent mineralocorticoid excess
21. Cortisone reductase deficiency: Evidence for a new inborn error in metabolism of adrenal steroids
22. A new defect in the peripheral conversion of cortisone to cortisol
23. Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency
24. Apparent cortisone reductase deficiency: A unique form of hypercortisolaemia
25. Defects in the HSD11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency
26. Profiling steroid hormones and urinary steroids
27. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo
28. The kidney is the major site of cortisone production in man
29. A radioimmunoassay for measuring androstenedione in serum and in blood spot samples from neonates
30. Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man
31. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess
32. Detection of glycyrrhetinic acid-like factors (GALFs) in human urine
33. Obesity and gender difference cortisol secretion and metabolism in man
34. 5α-Reductase activity in polycystic ovary disease
35. Hyperandrogenism in polycystic ovary syndrome: Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase
36. Cortisol effects on body mass, blood pressure and cholesterol in the general population